These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27856425)

  • 1. PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors.
    Haro MA; Littrell CA; Yin Z; Huang X; Haas KM
    Cancer Immunol Res; 2016 Dec; 4(12):1027-1037. PubMed ID: 27856425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
    O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO
    Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.
    Zhang S; Walberg LA; Ogata S; Itzkowitz SH; Koganty RR; Reddish M; Gandhi SS; Longenecker BM; Lloyd KO; Livingston PO
    Cancer Res; 1995 Aug; 55(15):3364-8. PubMed ID: 7614472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.
    Singhal A; Fohn M; Hakomori S
    Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified human anti-Tn and anti-T antibodies specifically recognize carcinoma tissues.
    Zlocowski N; Grupe V; Garay YC; Nores GA; Lardone RD; Irazoqui FJ
    Sci Rep; 2019 May; 9(1):8097. PubMed ID: 31147593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
    O'Boyle KP; Wright K
    Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
    Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
    J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn.
    O'Boyle KP; Coatsworth S; Anthony G; Ramirez M; Greenwald E; Kaleya R; Steinberg JJ; Dutcher JP; Wiernik PH
    Cancer Immun; 2006 Mar; 6():5. PubMed ID: 16524255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
    Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S
    Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates.
    Toyokuni T; Hakomori S; Singhal AK
    Bioorg Med Chem; 1994 Nov; 2(11):1119-32. PubMed ID: 7757411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.
    Ando H; Matsushita T; Wakitani M; Sato T; Kodama-Nishida S; Shibata K; Shitara K; Ohta S
    Biol Pharm Bull; 2008 Sep; 31(9):1739-44. PubMed ID: 18758069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.
    Ogata S; Maimonis PJ; Itzkowitz SH
    Cancer Res; 1992 Sep; 52(17):4741-6. PubMed ID: 1511439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity.
    Welinder C; Baldetorp B; Borrebaeck C; Fredlund BM; Jansson B
    Glycobiology; 2011 Aug; 21(8):1097-107. PubMed ID: 21470982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T/Tn immunotherapy avoiding immune deviation.
    Son HY; Apostolopoulos V; Kim CW
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):812-817. PubMed ID: 27760846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.
    Oppezzo P; Osinaga E; Tello D; Bay S; Cantacuzene D; Irigoín F; Ferreira A; Roseto A; Cayota A; Alzari P; Pritsch O
    Hybridoma; 2000 Jun; 19(3):229-39. PubMed ID: 10952411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
    Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
    Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple mucin-type carbohydrate antigens in major salivary glands.
    Therkildsen MH; Mandel U; Thorn J; Christensen M; Dabelsteen E
    J Histochem Cytochem; 1994 Sep; 42(9):1251-9. PubMed ID: 8064132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing.
    Trabbic KR; Kleski KA; Shi M; Bourgault JP; Prendergast JM; Dransfield DT; Andreana PR
    Cancer Immunol Immunother; 2018 Sep; 67(9):1437-1447. PubMed ID: 30030557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.